Business Wire

GMIS

7.9.2020 12:33:11 CEST | Business Wire | Press release

Share
The Global Manufacturing and Industrialisation Summit Joins Germany in the Fight Against Climate Change
  • GMIS partners with German organisations to launch ‘The Green Chain Initiative’, a multi-stakeholder effort to develop new renewable energy global value chains
  • The Initiative will link developed and developing countries by combining a crowd-sourcing platform with blockchain technologies to support the green agenda
  • Mass-scale decarbonisation of industry is essential in tackling climate change while also delivering sustainable industrial development
  • Initiative was endorsed by UNIDO and German organisations including BDI, DIHK, VDMA, ZVEI and GHORFA
  • The Initiative will promote clean energy, green products, and socially-responsible investments to drive carbon-neutrality

The Global Manufacturing and Industrialisation Summit (GMIS) today announced an unconventional global initiative, in partnership with leading German associations, to accelerate the decarbonisation of industry and the development of renewable energy projects supporting the global green agenda as well as Germany’s National Hydrogen Strategy . The ‘Green Chain Initiative’ aims to develop new, renewable energy value chains by combining a crowd-sourcing platform with blockchain technologies to promote inclusive and sustainable industrial development.

Inspired by Germany's leadership in driving clean technologies, and its ambitions for a net-zero carbon world, the pioneering ‘Green Chain Initiative’ was announced by Badr Al-Olama, Head of the GMIS Organising Committee, during the Virtual Edition of the Global Manufacturing and Industrialisation Summit (#GMIS2020). Also present during the announcement were Holger Lösch , Deputy Director General and member of the Executive Board of the Federation of German Industries (BDI), Dr. Volker Treier , Deputy Chief Executive Officer of the Association of German Chambers of Commerce and Industry (DIHK), and Dr Hiroshi Kuniyoshi , Deputy Director General and Managing Director, External Relations and Policy Research of the United Nations Industrial Development Organization .

Al-Olama said the pause in day-to-day human activities over the past few months highlighted just how big of an impact humanity was having on the planet. During lockdowns imposed by various governments to stall the spread of the pandemic, pollution levels in urbanised areas dropped dramatically, resulting in cleaner air in cities around the world.

“Taking the events of the past few months into consideration, we wanted to initiate a legacy that can truly make a difference to our world, ensuring green energy to make green products that can be bought using green currencies,” Al-Olama said. “Hence, I'm proud to formally announce, on behalf of the Organising Committee for #GMIS2020, our new legacy initiative called The Green Chain. The Green Chain Initiative will crowdsource renewable energy projects that will use 4IR technologies to create the outcome of a greener planet for all.

“This initiative truly converges the interests of governments – by providing new sources of green energy, with the interests of industries – that will produce green products by decarbonising their manufacturing facilities, with the interests of consumers – who are able to opt for green crypto-currencies to purchase these products. What is also unique about this initiative is that it includes all countries of the world, not just those with fossil fuel resources, and not just those with renewable energy. In that sense, what better partner for us to adopt and co-lead this initiative than Germany, a country with a proven track record in launching strategies for carbon neutrality.”

To define the concept and shape the objectives of the Initiative, GMIS formed a working group, comprised of leading industrial experts representing the United Nations Industrial Development Organisation (UNIDO), the Federation of German Industries (BDI), the Association of German Chambers of Commerce and Industry (DIHK), the Association of German Engineers (VDMA), the German Electrical, Electronic Manufacturers Association (ZVEI), and the Arab-German Chamber of Commerce and Industry (GHORFA).

Innovation to tackle climate change

Volker Treier said tackling climate change remains one of the major issues facing humanity. However, he said there needs to be a common understanding at a global level or at least a European understanding, to fully address the challenge.

“Right now Germany is a good role model, but we need a European approach in order to maintain competitiveness because we are a highly industrialised country,” he said. “The problem is that policy makers are acting more or less on a national basis, and not on a European or a multilateral fundament.”

Dr. Hiroshi Kuniyoshi pointed out that the International Energy Agency (IEA) has predicted that CO2 emissions in 2020 would fall by 8% compared to 2019 levels. Despite the massive slow-down in economic activities, this is still far below what is required to meet the targets of the Paris Agreement.

“We need to introduce something more, and that is innovation,” he said. “We need to introduce innovative technologies, including renewable energy and energy conservation technologies. Manufacturing and industry needs to help the whole world by actively working on that direction and we all need to work together to achieve this.”

Lösch said reductions in CO2 over the past few months had come at a very high price in terms of the disruption to people’s livelihoods and that the fallout from the coronavirus will likely continue for years to come. “To protect the climate we have to change everything about the way we are doing business, and therefore, we really have to focus on enormously intelligent and efficient ways to tackle this problem.”

Defossilsing the energy system globally is the main priority, he said, followed by major investments in energy efficiency, and followed by the ability to couple sectors intelligently, highlighting the example of getting the mobility sector to defossilise in combination with the energy sector. “All of this is very demanding, but it can be done by technology and by innovation. And this is, of course, a core competence of industry,” Lösch said.

Badr Al Olama, Head of the Organising Committee of the Global Manufacturing and Industrialisation , added: “#GMIS2020 was originally scheduled to be held in Germany alongside Hannover Messe in April before we shifted to our first Virtual Summit in line with COVID19 concerns. I am truly excited to advance our collaboration with Germany and launch the Green Chain Initiative. Together with Germany, we look forward to accelerating the decarbonisation of industry, through the transfer of knowledge and best practices, and addressing the challenges of climate change. The Green Chain Initiative will truly leave a legacy following #GMIS2020.”

Under the theme – Glocalisation: Towards Sustainable and Inclusive Global Value Chains , the #GMIS2020 Virtual Summit took place on September 4-5 and gathered a cross-section of close to 100 global leaders from the public and private sector participating across more than 20 virtual sessions. The first day of the Virtual Summit featured a series of keynote opening speeches and German-focused discussion on critical topics including Germany’s ‘Marshall Plan with Africa’ and the ‘Global Hydrogen Economy’. There was also a series of working group sessions which involved high-level representatives from industry and world-renowned organisations to discuss the development of a number of new initiatives the Summit plans to launch in the near future.

The second day of the Summit featured a series of keynote addresses and panel sessions involving Heads of State, Ministers, and thought-leaders from some of the world’s leading organisations. Discussions focused on the major issues facing the manufacturing sector and will explore how the adoption of 4IR technologies, localising production capabilities and capacity building, and spreading inclusive and sustainable development will all be critical to the future of global value chains.

END

About GMIS:

To learn more about GMIS, please visit https://gmisummit.com/

Link:

ClickThru

Social Media:

https://www.facebook.com/GMISummit/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye